Why Sonnet BioTherapeutics Holdings, Inc. (SONN) stock is rising today?
Sonnet BioTherapeutics Holdings, Inc. (SONN) today announced the completion of Licensing agreement with New Life Therapeutics(NLT) after which the SONN stock price saw an uptrend of 6.75% to reach $2.53 a share as of this writing. SONN stock soared in the previous trading session and went up by 17.91% at closing. Let’s deep dive to […]
Why Sonnet BioTherapeutics Holdings, Inc. (SONN) stock is rising today? Read More »